Neuromyelitis optica (NMOSD): open trials in United Kingdom

4 open trials have a site in United Kingdom. Registry data; only the trial team decides who can take part.

NCT05199688
A Study to Evaluate Pharmacokinetics, Efficacy, Safety, Tolerability, and Pharmacodynamics of Satralizumab in Pediatric Patients With Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorder (NMOSD)
Trial Treatment · Phase 3 · Hoffmann-La Roche
Great Ormond Street Hospital for Children, London
Registry updated 2026-10-01
NCT07704294
Early Prediction of Outcomes Following Optic Neuritis: Development and Acceptability of a Prognostic Tool
Research · King's College London
King's College Hospital NHS Foundation Trust, London · Guy's and St Thomas' NHS Foundation Trust, London · Moorfields Eye Hospital NHS Foundation Trust, London
Registry updated 2026-07-15
NCT06312644
Study of Ultomiris® (Ravulizumab) Safety in Pregnancy
Research · Alexion Pharmaceuticals, Inc.
London
Registry updated 2026-04-16
NCT05549258
Study of Inebilizumab in Pediatric Subjects With Neuromyelitis Optica Spectrum Disorder
Trial Treatment · Phase 2 · Amgen
Birmingham Women's and Children's NHS Foundation Trust, Birmingham · Great Ormond Street Hospital - PPDS, London · Evelina London Children's Hospital, London
Registry updated 2025-12-05

This page is not medical advice. Talk to your doctor before contacting a trial.

A Study to Evaluate Pharmacokinetics, Efficacy, Safety, Tolerability, and Pharmacodynamics of Satralizumab in Pediatric Patients With Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorder (NMOSD)